These findings together raise the question of whether impairment of the Ubiquitin Pathway on its own can promote increased mortality as a general mechanism underlying a broad spectrum of neurodegenerative diseases or if impairment of the Ubiquitin Pathway occurs largely as a side-effect in neurodegenerative processes. Here, UBB is linked to neurodegenerative disease.